|
|
 |
- Molecular biology and
biochemical aspects of heart failure
- Vascular biology,
endothelial function
- Apoptosis in vascular and
cardiac remodeling
- Genetic studies in
cardiomyopathy
- Gene transfer therapy in
heart failure
- Growth control and
cytokines in vascular cells
- Natriuretic peptides in
heart failure
- Endothelin in heart
failure
- Pharmacologic modulation
of vascular-endothelial function
- Neurohumoral, immunologic
aspects of heart failure
- Inflammatory mediators and
heart failure
- Diagnostic methods:
- Advances in echocardiography: contrast, TEE and 3D
- Nuclear cardiology - assessment of myocardial perfusion,
function and viability
- PET - new insights into myocardial metabolism
- Applications of cardiac magnetic resonance imaging
- Intracoronary flow, doppler measurements
- Heart failure due to
coronary artery disease
- Mechanisms involved in
myocardial stunning, hibernation and preconditioning
- Acute myocardial
infarction: thrombolysis and reperfusion
- Interventional cardiology
in acute infarction and angina
- Antithrombotic and
antiplatelet adjunctive therapy for PTCA
- Blockage of tissue
proliferation after coronary interventions
- Left ventricular
remodeling after myocardial infarction
- Secondary prevention of
CAD, risk stratification
- Hypertension and heart
failure, new therapeutic approaches
- Heart failure in women
- Dilated cardiomyopathy:
various etiologies
- Ischemic cardiomyopathy
- Left ventricular
hypertrophy
- Hypertrophic
cardiomyopathy
- Role of the pericardium
- Heart failure in valvular
heart disease
- Pulmonary circulation
aspects, pulmonary hypertension
- Heart failure in systemic
disease
- Heart failure in infancy
and childhood
- Preventative aspects of
heart failure
- Prognostic aspects of
heart failure
- Predictors and markers of
heart failure outcome
- Exercise physiology and
rehabilitation in heart failure
- Nursing aspects of heart
failure
- Epidemiology of heart
failure
- Renal aspects - diuretics
- Digoxin and other new
inotropic agents in heart failure
- ACE inhibitors and
Angiotensin - II receptor blockers, Organic nitrates -
their role in heart failure management
- Beta-blockers and beta-adrenergic
receptors in heart failure
- Calcium channel blockers
and promoters in heart failure
- Results of major clinical
trials
- Arrhythmias and
antiarrhythmic drug therapy in heart failure
- Atrial flutter /
fibrillation - electrophysiologic concepts and clinical
aspects
- Sudden death in heart
failure
- Advances in internal
defibrillation and implantable antiarrhythmic devices
- Cardiac pacing strategies
in heart failure
- Advances in congenital
heart disease
- New approaches to surgical
revascularization: minimally invasive surgery, TMLR
- Therapeutic and
physiologic issues surrounding heart valve surgery
- Mechanical support, left
ventricular assist devices
- Recovery of myocyte in
heart failure (role of assist device)
- Surgery for LV dysfunction
- Cardiac transplantation
- Practice guidelines, cost
containment
|
|
|
| |
|
|
